Quarterly report · Q2
7129.TEDINET S100S68R
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥22.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥25m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥7m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥20m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥169m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥11m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥40m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥54m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥810m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥676m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥144m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥557m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥103m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥621m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥369m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥446m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-13.06 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.8 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.83 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 24.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥452m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥431m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥383m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥243m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥86m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥245m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥408m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥443m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥430m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥393m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥240m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥61m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥204m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥383m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥400m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 549
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)史彩監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)伊 藤 肇 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 和 大 人 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 10931326000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 10993830000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 22249391000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -11227000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 20283000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 169277000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -44372000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -32515000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 209580000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -44338000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -32484000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 209585000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 3116160000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 3275521000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3337732000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 13614290000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 13501297000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 14135911000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -17.83 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -13.06 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 84.22 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 83.84 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.229 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.242 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.236 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 676420000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 810024000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1021308000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -103484000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -144296000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -556761000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -445904000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -620758000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -368673000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1213880000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1227691000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1182721000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 3.09 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 2.80 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2502300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2512300 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2502300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2512300 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |